Form 4: HCA Healthcare Executive Phillip G. Billington Reports Stock Transactions
SEC Form 4 Filing
Phillip G. Billington, SVP-Internal Audit Services at HCA Healthcare, reported the acquisition and disposal of company stock and stock appreciation rights.
Summary
- Phillip G. Billington, a Senior Vice President at HCA Healthcare, filed a Form 4 detailing his recent transactions in the company's stock.
- On November 12, 2024, Billington acquired 8,000 shares of common stock at a price of $68.96 per share through the exercise of stock appreciation rights.
- Also on November 12, 2024, 4,103 shares were disposed of at a price of $350.53 per share.
- On November 14, 2024, Billington sold 3,897 shares at $350 per share.
- Following these transactions, Billington beneficially owns 52,702.0749 shares of HCA Healthcare common stock.
- The report also notes that 2,367.0749 of the shares were acquired through the company's employee stock purchase plans.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions, with no indication of positive or negative sentiment. It is a routine filing.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice in publicly traded companies. It provides transparency into the trading activities of insiders.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, and HCA's filing is consistent with these requirements.
- The transactions reported are typical for executives who receive stock-based compensation and may exercise options or sell shares for personal financial management.
- Other healthcare companies such as Universal Health Services (UHS) and Tenet Healthcare (THC) also have executives who file similar Form 4 reports.
Stakeholder Impact
- The transactions may have a minor impact on the stock price, but are unlikely to be significant given the relatively small volume compared to the total shares outstanding.
- The filing provides transparency to shareholders regarding executive stock transactions.
Key Dates
| Date | Description |
|---|---|
| 2019-01-03 | Date of the Power of Attorney document. |
| 2024-02-04 | Start date of the vesting period for the stock appreciation rights. |
| 2024-11-12 | Date of stock acquisition and disposal. |
| 2024-11-14 | Date of stock disposal and filing of the Form 4. |
Keywords
HCA Healthcare, stock transactions, Form 4, insider trading, stock appreciation rights, Phillip G. Billington, executive compensation, employee stock purchase plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.